Degradation and Characterisation of Electrospun Polycaprolactone (PCL) and Poly(lactic-co-glycolic acid) (PLGA) Scaffolds for Vascular Tissue Engineering

被引:44
|
作者
Bazgir, Morteza [1 ]
Zhang, Wei [2 ,3 ]
Zhang, Ximu [4 ,5 ]
Elies, Jacobo [6 ]
Saeinasab, Morvarid [7 ]
Coates, Phil [8 ]
Youseffi, Mansour [1 ]
Sefat, Farshid [1 ,8 ]
机构
[1] Univ Bradford, Sch Engn, Dept Biomed & Elect Engn, Bradford BD7 1DP, W Yorkshire, England
[2] Sichuan Univ, Polymer Res Inst, State Key Lab Polymer Mat Engn, Chengdu 610065, Peoples R China
[3] Sichuan Univ, Adv Polymer Mat Res Ctr, Shishi 362700, Peoples R China
[4] Chongqing Med Univ, Chongqing Key Lab Oral Dis & Biomed Sci, Stomatol Hosp, Chongqing 401174, Peoples R China
[5] Chongqing Med Univ, Chongqing Municipal Key Lab Oral Biomed Engn High, Stomatol Hosp, Chongqing 401174, Peoples R China
[6] Univ Bradford, Fac Life Sci, Sch Pharm & Med Sci, Bradford BD7 1DP, W Yorkshire, England
[7] Ferdowsi Univ Mashhad, Fac Sci, Dept Biol, Mashhad 9177948974, Razavi Khorasan, Iran
[8] Univ Bradford, Interdisciplinary Res Ctr Polymer Sci & Technol P, Bradford BD7 1DP, W Yorkshire, England
关键词
electrospinning; polycaprolactone (PCL); Poly(lactic-co-glycolic acid) (PLGA); tissue engineering; porous biodegradable membrane; degradation; tensile test; MESENCHYMAL STEM-CELLS; IN-VITRO; NATURAL POLYMERS; PORE-SIZE; NANOENGINEERED BIOMATERIALS; MECHANICAL-PROPERTIES; POROUS STRUCTURE; ALIGNED PLGA; FABRICATION; BONE;
D O I
10.3390/ma14174773
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
The current study aimed to evaluate the characteristics and the effects of degradation on the structural properties of Poly(lactic-co-glycolic acid) (PLGA)- and polycaprolactone (PCL)-based nanofibrous scaffolds. Six scaffolds were prepared by electrospinning, three with PCL 15% (w/v) and three with PLGA 10% (w/v), with electrospinning processing times of 30, 60 and 90 min. Both types of scaffolds displayed more robust mechanical properties with increased spinning times. The tensile strength of both scaffolds with 90-min electrospun membranes did not show a significant difference in their strengths, as the PCL and PLGA scaffolds measured at 1.492 MPa +/- 0.378 SD and 1.764 MPa +/- 0.7982 SD, respectively. All membranes were shown to be hydrophobic under a wettability test. A degradation behaviour study was performed by immersing all scaffolds in phosphate-buffered saline (PBS) solution at room temperature for 12 weeks and for 4 weeks at 37 degrees C. The effects of degradation were monitored by taking each sample out of the PBS solution every week, and the structural changes were investigated under a scanning electron microscope (SEM). The PCL and PLGA scaffolds showed excellent fibre structure with adequate degradation, and the fibre diameter, measured over time, showed slight increase in size. Therefore, as an example of fibre water intake and progressive degradation, the scaffold's percentage weight loss increased each week, further supporting the porous membrane's degradability. The pore size and the porosity percentage of all scaffolds decreased substantially over the degradation period. The conclusion drawn from this experiment is that PCL and PLGA hold great promise for tissue engineering and regenerative medicine applications.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Biomimetic mineralization of electrospun poly (lactic-co-glycolic acid)/multi-walled carbon nanotubes composite scaffolds in vitro
    Zhang, Hualin
    Liu, Jinsong
    Yao, Zhiwen
    Yang, Jun
    Pan, Lingzhan
    Chen, Zhiqing
    MATERIALS LETTERS, 2009, 63 (27) : 2313 - 2316
  • [42] The influence of architecture on degradation and tissue ingrowth into three-dimensional poly(lactic-co-glycolic acid) scaffolds in vitro and in vivo
    Cao, Y
    Mitchell, G
    Messina, A
    Price, L
    Thompson, E
    Penington, A
    Morrison, W
    O'Connor, A
    Stevens, G
    Cooper-White, J
    BIOMATERIALS, 2006, 27 (14) : 2854 - 2864
  • [43] Comparative Study of Poly (ε-Caprolactone) and Poly(Lactic-co-Glycolic Acid) -Based Nanofiber Scaffolds for pH-Sensing
    Di, Wenjun
    Czarny, Ryan S.
    Fletcher, Nathan A.
    Krebs, Melissa D.
    Clark, Heather A.
    PHARMACEUTICAL RESEARCH, 2016, 33 (10) : 2433 - 2444
  • [44] In vitro evaluation of poly (lactic-co-glycolic acid)/polyisoprene fibers for soft tissue engineering
    Marques, Douglas R.
    dos Santos, Luis A. L.
    O'Brien, Marie A.
    Cartmell, Sarah H.
    Gough, Julie E.
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS, 2017, 105 (08) : 2581 - 2591
  • [45] Tuning the Size of Poly(lactic-co-glycolic Acid) (PLGA) Nanoparticles Fabricated by Nanoprecipitation
    Huang, Wei
    Zhang, Chenming
    BIOTECHNOLOGY JOURNAL, 2018, 13 (01)
  • [46] Particulate Systems Based on Poly(Lactic-co-Glycolic)Acid (pLGA) for Immunotherapy of Cancer
    Rahimian, Sima
    Fransen, Marieke F.
    Kleinovink, Jan Willem
    Amidi, Maryam
    Ossendorp, Ferry
    Hennink, Wim E.
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (29) : 4201 - 4216
  • [47] Incorporation of carboxylation multiwalled carbon nanotubes into biodegradable poly(lactic-co-glycolic acid) for bone tissue engineering
    Lin, Cuilin
    Wang, Yifang
    Lai, Youqun
    Yang, Wei
    Jiao, Fei
    Zhang, Honggang
    Ye, Shefang
    Zhang, Qiqing
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2011, 83 (02) : 367 - 375
  • [48] Benign preparation of aqueous core poly lactic-co-glycolic acid (PLGA) microcapsules
    Nomura, Toshiyuki
    Routh, Alexander F.
    JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2018, 513 : 1 - 9
  • [49] Importance of Poly(lactic-co-glycolic acid) in Scaffolds for Guided Bone Regeneration: A Focused Review
    Castillo-Dali, Gabriel
    Velazquez-Cayon, Rocio
    Angeles Serrera-Figallo, M.
    Rodriguez-Gonzalez-Elipe, Agustin
    Gutierrez-Perez, Jose-Luis
    Torres-Lagares, Daniel
    JOURNAL OF ORAL IMPLANTOLOGY, 2015, 41 (04) : E152 - E157
  • [50] Poly(lactic-co-glycolic) Acid (PLGA) Nanoparticles and Transdermal Drug Delivery: An Overview
    Kumar, Lalit
    Kukreti, Gauree
    Rana, Ritesh
    Chaurasia, Himanshu
    Sharma, Anchal
    Sharma, Neelam
    Komal
    CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (37) : 2940 - 2953